Lv4
722 积分 2025-11-11 加入
[Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]
2个月前
已完结
[Guideline for diagnosis and management of metabolic dysfunction-associated fatty liver disease in primary care (2025)]
2个月前
已完结
Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis
2个月前
已完结
Modulation of T cells by tryptophan metabolites in the kynurenine pathway
2个月前
已完结
Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration
2个月前
已完结
Bacteroides and related species: The keystone taxa of the human gut microbiota
3个月前
已完结
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
3个月前
已完结
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
3个月前
已完结
The gut-liver axis in liver disease: Pathophysiological basis for therapy
3个月前
已完结
Pathophysiology and therapeutic options for cirrhotic portal hypertension
3个月前
已完结
皖公网安备34019202002308
